STOCK TITAN

Ligand director Jason Haas proposes $2.09M share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Ligand Pharmaceuticals Inc. director Jason Haas reported a proposed sale of 7,138 common shares, with an approximate sale date of August 12, 2026, and an aggregate market value of $2,090,061.99. The notice also reports that he sold 6,461 common shares on June 12, 2026, for gross proceeds of $1,651,320.33.

Proposed shares for sale 7,138 common shares Approximate sale date August 12, 2026
Aggregate market value $2,090,061.99 For 7,138 common shares proposed for sale
Common shares outstanding 19,935,609 shares Issuer's reported outstanding share count
Prior shares sold 6,461 common shares Sale on June 12, 2026
Gross proceeds $1,651,320.33 Sale of 6,461 common shares on June 12, 2026
Shares acquired through stock option exercise 2,759 common shares Acquired August 12, 2026
Shares acquired through stock option exercise 3,379 common shares Acquired August 12, 2026
Restricted stock acquired 1,000 common shares Acquired June 29, 2025
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Stock Option Exercise financial
"Nature of Acquisition Transaction: Stock Option Exercise"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
Restricted Stock financial
"Nature of Acquisition Transaction: Restricted Stock"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Gross Proceeds financial
"Amount of Securities Sold | Gross Proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LGND shares did Jason Haas report for sale?

Jason Haas reported a proposed sale of 7,138 common shares, with an aggregate market value of $2,090,061.99 and an approximate sale date of August 12, 2026.

How did Jason Haas acquire the LGND shares listed for sale?

The notice lists 2,759 and 3,379 common shares acquired from the issuer through stock option exercises on August 12, 2026, and 1,000 common shares acquired from the issuer as restricted stock on June 29, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading